Ikarian Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-33,100
| Closed | -$1.23M | – | 121 |
|
|
2023
Q1 | $1.23M | Sell |
33,100
-75,000
| -69% | -$2.79M | 0.28% | 45 |
|
|
2022
Q4 | $4.9M | Buy |
+108,100
| New | +$4.9M | 1.18% | 19 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 179 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 191 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 202 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 245 |
|
|
2021
Q1 | – | Sell |
-3,557
| Closed | -$781K | – | 256 |
|
|
2020
Q4 | $781K | Sell |
3,557
-35,000
| -91% | -$7.68M | 0.03% | 95 |
|
|
2020
Q3 | $6.4M | Buy |
+38,557
| New | +$6.4M | 0.46% | 18 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 139 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 121 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 82 |
|